Get the Stockscreener App
0.69
6.15%
0.0399
Pre-market:
.72
0.0301
+4.36%
Immunic Inc stock is traded at $0.69, with a volume of 1.00M.
It is up +6.15% in the last 24 hours and down -0.17% over the past month.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
See More
Previous Close:
$0.65
Open:
$0.65
24h Volume:
1.00M
Relative Volume:
0.72
Market Cap:
$82.99M
Revenue:
-
Net Income/Loss:
$-93.61M
P/E Ratio:
-0.327
EPS:
-2.11
Net Cash Flow:
$-71.16M
1W Performance:
-1.58%
1M Performance:
-0.17%
6M Performance:
-10.97%
1Y Performance:
-44.80%
1-Day Range:
$0.63
$0.69
1-Week Range:
$0.63
$0.72
52-Week Range:
$0.561
$1.39
Immunic Inc Stock (IMUX) Company Profile
Name
Immunic Inc
Sector
Industry
Phone
(332) 255-9818
Address
1200 AVENUE OF THE AMERICAS, NEW YORK
Compare IMUX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.69 | 78.19M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Initiated | Roth Capital | Buy |
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-25-25 | Initiated | William Blair | Outperform |
| Nov-25-24 | Initiated | H.C. Wainwright | Buy |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Aug-27-24 | Initiated | B. Riley Securities | Buy |
| Oct-21-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Apr-15-21 | Initiated | Aegis Capital | Buy |
| Mar-24-21 | Initiated | JMP Securities | Mkt Outperform |
| Oct-02-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-20 | Initiated | Piper Sandler | Overweight |
| Aug-07-20 | Resumed | ROTH Capital | Buy |
| Jul-20-20 | Initiated | BMO Capital Markets | Outperform |
| Jun-05-20 | Initiated | Wedbush | Outperform |
| May-11-20 | Initiated | H.C. Wainwright | Buy |
| Mar-25-20 | Initiated | ROTH Capital | Buy |
| Jul-11-19 | Initiated | Chardan Capital Markets | Buy |
View All
Immunic Inc Stock (IMUX) Latest News
How supply chain issues affect Immunic Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Why Immunic Inc. (10VA) stock is a strong analyst pickPortfolio Gains Summary & Technical Pattern Alert System - Newser
Can Immunic Inc. (10VA) stock withstand sector downturnsTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Is Immunic Inc. stock near bottom after declineOil Prices & Daily Momentum Trading Reports - Newser
How Immunic Inc. stock performs in stagflation2025 Investor Takeaways & Target Return Focused Picks - Newser
Immunic marks International Day of Persons with Disabilities with hope for MS sufferers - Proactive financial news
What consensus target says about Immunic Inc. (10VA) stockWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Immunic Inc. stock is considered a top pickPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Will Immunic Inc. (10VA) stock outperform Dow JonesTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Will Immunic Inc. (10VA) stock outperform global peers2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - Sahm
What is B. Riley’s Forecast for Immunic FY2025 Earnings? - Defense World
Will Immunic Inc. (10VA) stock benefit from mergersWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
What is B. Riley’s Estimate for Immunic Q1 Earnings? - Defense World
B. Riley Forecasts Immunic's Q1 Earnings (NASDAQ:IMUX) - MarketBeat
Immunic announces attendance at upcoming Evercore ISI Healthcare Conference - Proactive financial news
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Analysts Offer Predictions for Immunic FY2025 Earnings - Defense World
Immunic (NASDAQ:IMUX) Upgraded at Chardan Capital - Defense World
Immunic Inc. (IMUX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Immunic Inc. stock performs in weak economyJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Is Immunic Inc. stock a buy before product launchesQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
Why Immunic Inc. stock is trending among retail traders2025 Institutional Moves & Weekly Watchlist for Consistent Profits - newser.com
Forecasting Immunic Inc. price range with options dataWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Will Immunic Inc. (10VA) stock return to pre crash levelsJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Chardan Capital Initiates Coverage of Immunic (IMUX) with Buy Recommendation - MSN
Using portfolio simulators with Immunic Inc. includedJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Immunic Inc (IMUX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Tangible book value per share of Immunic, Inc. – HAM:10VA - TradingView
Immunic (IMUX) Price Target Decreased by 14.49% to 5.48 - MSN
HC Wainwright Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00 - Defense World
Immunic price target lowered to $8 from $10 at H.C. Wainwright - MSN
News impact scoring models applied to Immunic Inc.2025 Trading Recap & Daily Stock Trend Reports - newser.com
Is Immunic Inc. stock a top momentum playProduct Launch & Accurate Technical Buy Alerts - newser.com
Is Immunic Inc. stock resilient to inflationJuly 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Immunic Inc Stock (IMUX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Immunic Inc Stock (IMUX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):